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Abstract
Background: An unfavorable condition for bone healing is the presence of bone defects. Under such conditions, a
material can play a role to cover fractured or defective bone. Technological advances now allow for the use of such
material. Hyalonect® (Fidia Advanced Biopolymers SLR, Italy), a novel membrane comprising knitted fibers of esterified
hyaluronan (HYAFF11) can be used to cover fractured or grafted bone and can also serve as a scaffold to keep
osteoprogenitor cells in place. The aim of this study was to compare osteoblastic activity by the use of scintigraphic
methods in defective rabbit tibias during early-phase bone healing with or without a hyaluronan-based mesh.
Methods: Two groups (A and B) of New Zealand albino rabbits were used; each group included 10 animals.
Operations on all rabbits were performed under general anesthesia. We also resected 10-mm bone segments from
each animal’s tibial diaphysis. After resection, tibias with defects were fixed using Kirschner wires. In group A, no
hyaluronan-based mesh was used. In group B, tibial segmental defects were enclosed with a hyaluronan-based mesh.
The rabbits were followed up for 4 weeks postoperatively, after which bone scintigraphic studies were performed on
each animal to detect and compare osteoblastic activity.
Results: The mean count in the fracture side of the hyaluronan-based mesh group was significantly higher compared
to that of the group A (p = 0.019). However, there was no significant difference between group B and control rabbits
with respect to the mean count on the intact bone side (p = 0.437). The bone defect (fracture)/intact bone mean count
ratio was significantly higher in group B compared to group A (p = 0.008).
Conclusions: A hyaluronan-based mesh plays a role in promoting osteoblastic activity. Hyalonect® is suitable for
restoring tissue continuity whenever the periosteal membrane is structurally impaired or inadequate. Our results
demonstrated that, during early-phase bone healing, osteoblastic activity was increased in bone defect sites when a
hyaluronan-based mesh was also used. The most important aspect of this study concerns its scintigraphy-based design.
This study is the first to use a scintigraphic method to demonstrate the effectiveness of hyaluronic acid-based material
for bone healing.
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Background
During trauma or surgery, disruption in the periosteum
can occur at the fracture site. The periosteum provides
external blood supply to the bone and plays an import-
ant role in healing. Given its importance to bone vitality,
maximum attention must be directed toward the preser-
vation of the periosteum during fracture surgery [1]. An
impaired periosteum can cause deterioration in the bio-
logical environment of the bone, which may affect pa-
tients’ treatment results and quality of life negatively,
even when an appropriate fixation technique is used.
The presence of bone defects represents another un-
favorable condition for bone healing. Callus formation
and the maintenance of bone integrity are significantly
more difficult with larger defects, which are frequently
filled using autografts or allografts [2]. Allografts are
predominantly osteoconductive, whereas autografts are,
to a certain extent, both osteoconductive and osteoin-
ductive [3, 4]. For allografts in particular, the presence of
osteoprogenitor or mesenchymal stem cells must pre-
cede the fracture site and then be maintained to achieve
healing; this process is more difficult when the perios-
teum is impaired. Under such conditions, a material can
play a role to cover fractured or defective bone. Innova-
tions and technological advances have rendered this pos-
sible through the use of a hyaluronan-based mesh,
which can be used to cover fractured or grafted bone
and can also provide a scaffold to keep osteoprogenitor
cells in place [5–7]. Hyalonect®, a bio-resorbable knitted
mesh used during orthopedic trauma and reconstructive
surgery, is composed of HYAFF®, a benzyl ester of hya-
luronic acid (HA) and natural component of the extra-
cellular matrix. The mesh is resorbable and may be fixed
to the surgical site by applying sutures or internal bone
fixation devices.
Bone scintigraphy, a radionuclide bone metabolism
imaging technique that is highly sensitive to osteoblastic
activity in the skeleton, can measure the distribution of a
radiolabelled phosphorous compound (99mTc-MDP)
around the defect site [8]. The technique is dependent
on bone metabolism rate and blood flow [9]. The aim of
this study was to compare osteoblastic activity in defect-
ive rabbit tibias during early-phase bone healing, using a
scintigraphic method with or without a hyaluronan-
based mesh.
Methods
Twenty adult male New Zealand white rabbits, aged
12 months and weighing 4000–4500 g, were included in
the study. The study protocol was approved by the local
Ethics Committee (Çukurova Medical School No. 7; 30 Oc-
tober 2014). The rabbits received care in accordance with
the guidelines of the Ethics Committee pertaining to the
use of animals in experimental studies. We randomly
assigned the rabbits into two groups (A and B; both n = 10).
Surgical procedure
First, 22-G catheters were placed in the lateral auricular
vein of the rabbits, who were anesthetized by injecting
10 mg/kg of propofol. During surgery, the 10 mg/ml
propofol solution was infused at a rate of 30 ml per hour
as necessary. A tibial diaphysial segmental bone defect
approximately 10 mm in diameter was created using an
oscillating saw blade. Saline irrigation was used to pre-
vent thermal bone necrosis. Hyaluronan-based mesh re-
placement was performed in accordance with the study
design. After resection, tibias with defects were fixed
using Kirschner wires (K-wires). In group A, no
hyaluronan-based mesh was used (Fig. 1a), whereas tibial
segmental defects were enclosed with a hyaluronan-
based mesh in group B (Fig. 1b). Iliac wings of the rab-
bits were prepared for all rabbits, and blood was aspi-
rated from the iliac wings which provided a source of
mesenchymal stem cells for stimulating and accelerating
bone healing process. In both groups, blood aspirated
from the iliac wings of the rabbits was injected (2 cm3)
into the tibial defects. Surgery was then completed with
suturing and dressing of the surgical wounds. Long leg
castings were then performed. The animals were exam-
ined regularly everyday to assess complications and
wound healing using a cast window; all received the
same amount and quality of food.
During the 2-week follow-up period, one rabbit in
each group died due to wound complications. After
2 weeks, long leg casts were removed. The remaining 18
rabbits were followed up for 4 weeks postoperatively. At
the end of this period, bone scintigraphy was performed
on each rabbit to assess osteoblastic activity.
Scintigraphic study
The operations were performed using radionuclide bone
imaging in both groups at 4 weeks postoperatively. Dur-
ing scanning, the animals were under ketamine hydro-
chloride anesthesia; they were placed in a supine
Group A (Control rabbit)                        Group B (Hyaluronan- based mesh rabbit)
X3 magnification X10magnification
Fig. 1 a Intraoperative image in group A (control group). b
Intraoperative image in group B (hyaluronan-based mesh group)
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position on the scanner bed, with their hind paws
stretched and fixed in a custom-made wooden holder.
Each animal was given an intravenous injection of
18.5 MBq/kg bolus technetium-99m methylene dipho-
sphonate (99mTc-MDP; Eczacibasi Monrol, Kocaeli,
Turkey). Three-phase radionuclide imaging was started
using a gamma camera (Philips Medical Systems Bright-
view, Best, Holland) equipped with a low-energy, high-
resolution, pinhole collimator set at 140 KeV with a
20 % window and 64 × 64 matrix size, immediately after
injection for 2 min. Static images were obtained 4 h after
injection of a radiotracer in a 256 × 256 matrix. We ana-
lyzed images to identify regions of interest (ROIs) on the
intact and fractured sides (Fig. 2). All ROIs were identi-
cal in size and shape. Total radioactivity counts in each
ROI and the intake ratio (average counts on the frac-
tured side/average counts at the intact side) were de-
rived and compared between the groups.
Statistical analysis
Sample size estimation
The primary aim of this study was to compare differ-
ences in the arithmetic mean ratio (i.e., bone defect
[(fracture)/bone] between the control and hyaluronan-
based mesh groups. A total sample size of 16 (n = 8 for
each group) was required to detect an at least 0.11
difference between the groups with a power of 80 % at
the 5 % significance level. This difference was taken
from both the pilot study and our clinical experiments.
Sample size estimation was performed using the
G*Power software package (ver. 3.0.10; Kiel, Germany).
Data analysis was performed using the SPSS for Win-
dows software package (ver. 11.5; SPSS Inc., Chicago, IL,
USA). The normality of the distribution of continuous
variables was determined using Shapiro-Wilk test. Data
are provided as means ± SD. Group differences in clin-
ical measurements (i.e., scintigraphic counts on fracture
and normal bone and ratio of these values) were
assessed using Student’s t test. A p value <0.05 was taken
to indicate statistical significance.
Results
The mean count/pixel ratio on the bone defect (fracture)
side in the hyaluronan-based mesh group was signifi-
cantly higher compared to that in the group A (p =
0.019). However, there was no significant difference be-
tween the hyaluronan-based mesh and control rabbits in
mean count/pixel ratio on the intact bone side (p =
0.437; Table 1).
The bone defect (fracture)/bone mean count/pixel ra-
tio was significantly higher in group B compared to
group A (p = 0.008; Table 1).
Group A (control group)
Group B (Hyaluronan-based   mesh group)
a b
a b
Fig. 2 a (a) Radionuclide imaging in group A (control group). (b) The black arrow shows the zoom image of the indicator of the ROI in group A
(control group). b (a) Radionuclide imaging in group B (hyaluronan-based mesh group). (b) The black arrow shows the zoom image of the
indicator of the ROI in group B (hyaluronan-based mesh group)
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Discussion
The major finding of this study was during early-phase
bone healing, osteoblastic activity is increased in the de-
fect site due to more rapid bone metabolism when a
hyaluronan-based mesh is also used.
Commensurate with recent biotechnological advances,
surgeons now aim to replace tissues that are injured, are
irreparable, or possess low regeneration potential with
biosynthetic materials possessing the same function or
structure. One such biosynthetic material is Hyalonect®,
which has been used previously for chondral lesions and
also has the potential to participate in periosteal regener-
ation due to its hyaluronate structure, which plays a role
in extracellular matrix formation, angiogenesis, and
osteogenesis [7, 10, 11]. Rhodes et al. [5] reported that
Hyalonect® is capable of restoring the function of dam-
aged connective tissues such as the periosteum without
interfering with the natural tissue repair process.
Numerous imaging modalities are used to assess fracture
healing. Traditionally, plain radiographs have been
employed to serially follow callus formation. The theoretical
basis for the use of 99mTc-labeled phosphates in the diagno-
sis of bone pathology is based on their high affinity for hy-
droxyapatite and immature collagen. 99mTc-MDP is
adsorbed selectively onto the mineral phase of forming
bone (via hydroxyapatite crystals) [8]. The accumulation of
technetium-99m-labeled diphosphonates is remarkably
consistent with the amount of mineralization caused by the
activity of osteoblastic cells following the onset of calcifica-
tion. An approximately 10 % increase in osteoblastic activ-
ity, above normal levels, can be detected by scintigraphic
studies but cannot be seen on conventional radiographs [8].
Unlike radiographic and histologic methods, bone scinti-
graphic images can reveal early bone mineralization in the
skeleton during the healing process [12, 13]. Bone scintig-
raphy is a feasible, easily applied, reproducible method for
objective assessment of bone healing [8].
In this study, we demonstrated the periosteum-like ac-
tivity of this biomaterial and its role in promoting osteo-
blastic activity. The most important aspect of this study
lies in its scintigraphy-based design. The results indicate
that, during early-phase bone healing, osteoblastic activ-
ity is increased in the defect site due to more rapid bone
metabolism when a hyaluronan-based mesh is also used.
The hyaluronan-based mesh group exhibited the highest
count/pixel ratio, for coated hyaluronan-based mesh
sites, indicative of extensive osteoblastic activity and in-
creased metabolism.
Several studies have demonstrated osteoblastic activity-
promoting effects of a hyaluronan-based mesh. In one such
preclinical study, conducted by Rhodes et al., holes were
drilled in the humerus of the canines [5]. The holes were
then filled with bone graft materials and surrounded with a
hyaluronan-based mesh. Histologic evaluation demon-
strated the effect of the hyaluronan-based mesh on healing;
the material surrounded the tissues, and a greater number
of host cells and reduced fibrous tissue formation were
evident.
In another study, Aslan et al. formed bone cavities in
the tibias of rabbits [14]. In one group, the cavities were
filled only with spongiosal bone graft. In another group,
they were filled with a viscoelastic preparation of hyalur-
onic acid in addition to spongiosal bone grafts. The hya-
luronic acid group had higher histopathologic scores
compared to the graft-only group. Ayanoğlu et al.
showed that Hyalonect® and grafting significantly en-
hance the healing process when used alone or together.
The use of both Hyalonect® and grafting together re-
sulted in better early radiological healing than bone
grafting alone [15]. Tekin et al. reported that Hyalonect®
use during surgical treatment of long-bone non-infected
pseudoarthrosis is a safe method that promotes bone
union [6]. In their study, a pseudoarthrosis site was fix-
ated internally and filled with allografts surrounded with
Hyalonect®; union was achieved in all patients after ap-
proximately 6 months. The findings from our studies are
consistent with those cited in previously published stud-
ies. The results of our study demonstrated that Hyalo-
nect® significantly increases the osteoblastic activity.
The main limitation of the study is the experimental
study performed on tibial diaphysial defect of rabbits, and
hence, we cannot be sure of the same beneficial effect of a
hyaluronan-based mesh on human bones unless we per-
form a clinical study. We also did not use other bone sub-
stitutes to compare the results. Further studies should be
performed to compare Hyalonect® with other bone substi-
tutes. Another limitation of the study is that we also did
not use biomechanic, radiographic, and histologic methods
to compare the results.
Hyalonect® is suitable for restoring tissue continuity
whenever the periosteal membrane is structurally im-
paired or inadequate and plays a role in promoting
osteoblastic activity. This study demonstrated that, dur-
ing early-phase bone healing, osteoblastic activity was
increased in bone defect sites when a hyaluronan-based
mesh was also used.
Conclusions
Hyaluronic acid is an important extracellular matrix
element due to its effects on processes such as cellular
Table 1 Scintigraphy counts in group A and group B
Variable Group A (n = 9) Group B (n = 9) p value*
Bone defect (fracture) 2768.6 ± 257.34 3203.7 ± 428.15 0.019
Bone 1649.2 ± 101.36 1688.2 ± 106.30 0.437
Ratio 1.68 ± 0.095 1.89 ± 0.188 0.008
Values are given as means ± SD
*Student’s t test. p value <0.05 was taken to indicate statistical significance
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vitality, adhesion, interaction, migration, osteoblastic ac-
tivity, and tissue repair [16–22]. This study is the first to
use a scintigraphic method to demonstrate the effective-
ness of a hyaluronic acid-based material for bone heal-
ing. A hyaluronan-based mesh plays a role in promoting
osteoblastic activity. Hyalonect® is suitable for restoring
tissue continuity whenever the periosteal membrane is
structurally impaired or inadequate. By fulfilling these
functions, artificial hyaluronic acid-based materials cover
bare bone or bone grafts, thereby facilitating the treat-
ment of fractures, non-unions, or pseudoarthrosis in a
safer and more effective manner. A hyaluronan-based
mesh can be used in such cases.
Future
In the near future, innovations will contribute greatly to-
ward tissue engineering in the area of orthopedics, par-
ticularly with respect to the cartilage and periosteum.
Significantly improved comfort and easier healing will be
possible, and the success rate of orthopedic treatment
will improve.
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